zydus cadila
Zydus Cadila starts supply of COVID-19 vaccine to govt
ZyCoV-D is a three-dose vaccine administered intradermally
Centre places purchase order for Zydus Cadila's needle-free Covid vaccine
ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above
Zydus Cadila to reduce its Covid vaccine price to Rs 265 a dose, final decision soon
The company's Covid vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20
ZyCoV-D to be introduced in Covid vaccination drive shortly: Govt
ZyCoV-D has received the Emergency Use Authorisation from the Drugs Controller General of India (DCGI)
Zydus Cadila to seek approval for two-dose regimen of its approved three-dose vaccine
The trials for the two-dose regimen are underway
More clarity on ZyCOV-D vaccine price by next week, says Zydus Group MD Sharvil Patel
Zydus Cadila announced that once they get clearance then they are expected to supply 5 crores doses per month till December 21
Centre says Zydus Cadila's vaccines for children may be available in near future
Zydus Cadila has concluded its trial for children between the age group of 12 to 18
Emergency approval for Zydus Cadila to take few more days, say sources
ZyCoV-D is a DNA Covid vaccine, which carries the genetic code for that part of a virus that triggers the immune system of the body
India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial
The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients
Seven Indian pharma players race to develop vaccine for deadly coronavirus
Leading vaccine major Serum Institute of India has said that it is hoping to develop a COVID-19 vaccine by the year-end